Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells.

Bispecific nanoparticles HIV NK cells Polarization

Journal

Nano today
ISSN: 1748-0132
Titre abrégé: Nano Today
Pays: England
ID NLM: 101297352

Informations de publication

Date de publication:
Feb 2021
Historique:
entrez: 16 8 2021
pubmed: 17 8 2021
medline: 17 8 2021
Statut: ppublish

Résumé

HIV represents a persistent infection which negatively alters the immune system. New tools to reinvigorate different immune cell populations to impact HIV are needed. Herein, a novel nanotool for the specific enhancement of the natural killer (NK) immune response towards HIV-infected T-cells has been developed. Bispecific Au nanoparticles (BiAb-AuNPs), dually conjugated with IgG anti-HIVgp120 and IgG anti-human CD16 antibodies, were generated by a new controlled, linker-free and cooperative conjugation method promoting the ordered distribution and segregation of antibodies in domains. The cooperatively-adsorbed antibodies fully retained the capabilities to recognize their cognate antigen and were able to significantly enhance cell-to-cell contact between HIV-expressing cells and NK cells. As a consequence, the BiAb-AuNPs triggered a potent cytotoxic response against HIV-infected cells in blood and human tonsil explants. Remarkably, the BiAb-AuNPs were able to significantly reduce latent HIV infection after viral reactivation in a primary cell model of HIV latency. This novel molecularly-targeted strategy using a bispecific nanotool to enhance the immune system represents a new approximation with potential applications beyond HIV.

Identifiants

pubmed: 34394703
doi: 10.1016/j.nantod.2020.101056
pmc: PMC8360327
mid: NIHMS1653524
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI118411
Pays : United States

Références

Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13193-7
pubmed: 9371822
J Virol. 2011 Jul;85(14):7029-36
pubmed: 21543485
Nature. 2012 Jul 25;487(7408):482-5
pubmed: 22837004
Eur J Pharm Biopharm. 2019 May;138:48-63
pubmed: 29879528
Front Immunol. 2020 Apr 28;11:789
pubmed: 32425949
J Virol. 1993 Aug;67(8):4785-96
pubmed: 7687303
Nat Immunol. 2008 May;9(5):495-502
pubmed: 18425106
J Immunol. 1989 Jan 15;142(2):431-8
pubmed: 2463307
Nano Lett. 2009 Feb;9(2):666-71
pubmed: 19199758
Biomaterials. 2017 Feb;117:44-53
pubmed: 27936416
J Chem Theory Comput. 2008 May;4(5):819-34
pubmed: 26621095
J Virol. 1994 Dec;68(12):8350-64
pubmed: 7525988
J Virol. 2014 Nov;88(21):12895-906
pubmed: 25165110
Immunol Rev. 2017 Jan;275(1):271-284
pubmed: 28133809
Clin Immunol. 2009 Dec;133(3):393-401
pubmed: 19828380
J Immunol. 2002 Jun 1;168(11):5764-70
pubmed: 12023377
Immunol Rev. 2015 Nov;268(1):296-310
pubmed: 26497529
J Immunol. 2007 Aug 15;179(4):2642-50
pubmed: 17675528
Small. 2013 Nov 25;9(22):3771-7
pubmed: 23788508
J Immunol Methods. 2006 Jan 20;308(1-2):53-67
pubmed: 16343526
J Immunol. 2012 Aug 1;189(3):1491-9
pubmed: 22745371
Front Immunol. 2017 Jun 28;8:760
pubmed: 28702032
Lancet HIV. 2014 Oct;1(1):e13-21
pubmed: 26423811
Biol Proced Online. 2009 May 15;11:32-51
pubmed: 19495910
Acc Chem Res. 2017 Aug 15;50(8):1911-1919
pubmed: 28771322
J Immunol Methods. 2018 Sep;460:26-35
pubmed: 29894750
Blood. 2006 Jan 1;107(1):159-66
pubmed: 16150947
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1994 Dec;50(6):5072-5076
pubmed: 9962592
J Virol. 2015 Oct;89(20):10176-89
pubmed: 26223643
Biophys J. 2005 Mar;88(3):1778-98
pubmed: 15738466
Langmuir. 2017 Dec 19;33(50):14502-14512
pubmed: 29199832
Curr Opin Immunol. 2016 Jun;40:24-35
pubmed: 26963133
Mol Cancer Ther. 2012 Dec;11(12):2674-84
pubmed: 23075808
J Virol. 2012 May;86(9):5014-25
pubmed: 22379105
Bioconjug Chem. 2017 Jan 18;28(1):11-22
pubmed: 28095686
Nat Protoc. 2009;4(2):256-69
pubmed: 19197269
J Immunol. 2013 Apr 15;190(8):4315-23
pubmed: 23509345
J Virol. 2017 Nov 14;91(23):
pubmed: 28956765
Nat Nanotechnol. 2008 Mar;3(3):145-50
pubmed: 18654486
J Control Release. 2017 Nov 10;265:57-65
pubmed: 28428065
J Virol. 1999 Nov;73(11):8966-74
pubmed: 10516002
Bioconjug Chem. 2017 Jan 18;28(1):88-97
pubmed: 27997136
PLoS One. 2015 Nov 10;10(11):e0135594
pubmed: 26555337
Nat Mater. 2004 May;3(5):330-6
pubmed: 15098025
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Anal Chem. 2014 Aug 19;86(16):8158-66
pubmed: 25048623
Chem Commun (Camb). 2011 Jan 7;47(1):445-7
pubmed: 20886126
Nat Nanotechnol. 2017 Aug;12(8):763-769
pubmed: 28459470
Chembiochem. 2008 Sep 1;9(13):2127-34
pubmed: 18698565
Front Immunol. 2019 May 22;10:1124
pubmed: 31191520
PLoS Pathog. 2014 Nov 13;10(10):e1004473
pubmed: 25393648
Curr Opin Biotechnol. 1996 Feb 1;7(1):72-7
pubmed: 8791316
Clin Cancer Res. 2013 Jul 15;19(14):3844-55
pubmed: 23690482
J Phys Chem B. 2006 Apr 13;110(14):7238-48
pubmed: 16599493
Beilstein J Nanotechnol. 2017 Jan 25;8:244-253
pubmed: 28243563
Nat Med. 2017 Nov;23(11):1271-1276
pubmed: 28967921
Nat Med. 2017 Nov;23(11):1277-1286
pubmed: 29035370
Phys Rev Lett. 2007 Nov 30;99(22):226106
pubmed: 18233304
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2365-8
pubmed: 2784570
J Exp Med. 2007 Nov 26;204(12):3027-36
pubmed: 18025129
Nat Nanotechnol. 2012 Dec;7(12):779-86
pubmed: 23212421
J Clin Invest. 2000 Oct;106(7):839-45
pubmed: 11018071
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16725-30
pubmed: 18936487
Nature. 2015 Jan 15;517(7534):381-5
pubmed: 25561180
Small. 2012 Dec 21;8(24):3714-9; author reply 3720-6
pubmed: 23180635
Structure. 2016 May 3;24(5):697-709
pubmed: 27041594
Langmuir. 2011 Sep 6;27(17):11098-105
pubmed: 21728302
Nanoscale. 2017 May 11;9(18):6111-6121
pubmed: 28447703
ACS Nano. 2010 Jul 27;4(7):3623-32
pubmed: 20553005
J Virol. 1995 Sep;69(9):5723-33
pubmed: 7543586
Future Med Chem. 2015;7(9):1097-107
pubmed: 26132521
J Immunol. 1985 Feb;134(2):971-6
pubmed: 3871222
Biophys J. 2010 Dec 1;99(11):3629-38
pubmed: 21112287
Nano Res. 2020 Mar;13(3):736-744
pubmed: 34079616
Nature. 1962 Nov 3;196:476-7
pubmed: 13998030
Carbohydr Polym. 2019 Mar 1;207:806-814
pubmed: 30600069
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14541-6
pubmed: 20679244

Auteurs

Antonio Astorga-Gamaza (A)

Infectious Disease Department, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Michele Vitali (M)

Infectious Disease Department, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Mireya L Borrajo (ML)

Infectious Disease Department, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Rosa Suárez-López (R)

Departament de Química, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.

Carlos Jaime (C)

Departament de Química, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.

Neus Bastus (N)

Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.

Carla Serra-Peinado (C)

Infectious Disease Department, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Laura Luque-Ballesteros (L)

Infectious Disease Department, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Oscar Blanch-Lombarte (O)

IrsiCaixa AIDS Research Institute, Badalona, Spain.
Germans Trias i Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain.

Julia G Prado (JG)

IrsiCaixa AIDS Research Institute, Badalona, Spain.
Germans Trias i Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain.

Juan Lorente (J)

Otorhinolaryngology Department, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

Felix Pumarola (F)

Otorhinolaryngology Department, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

Marc Pellicer (M)

Otorhinolaryngology Department, Vall d'Hebron University Hospital, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

Vicenç Falcó (V)

Infectious Disease Department, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Meritxell Genescà (M)

Infectious Disease Department, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Víctor Puntes (V)

Infectious Disease Department, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.

Maria J Buzon (MJ)

Infectious Disease Department, Hospital Universitario Vall d'Hebron, Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Classifications MeSH